康希诺生物(06185)今日盘中股价大幅上涨5.09%，引起了市场关注。
消息面上，全国政协委员、康希诺生物首席科学官朱涛在今年全国两会期间提出建议，聚焦青少年及成人疫苗接种，呼吁构建并完善全生命周期免疫规划体系。朱涛建议推动免疫规划从“婴幼儿重点覆盖”向“全人群动态保障”转型，建立动态评估机制以适时扩大免疫规划品类与年龄范围，并深化医防融合接种服务模式。此外，他还建议优化疫苗支付政策，扩大医保个人账户可支付疫苗品类，并支持商业保险开发相关产品。
市场分析认为，这些建议若被采纳，将有望扩大疫苗市场的整体需求，对以疫苗研发和生产为主营业务的康希诺生物构成直接利好，从而推动了其股价在盘中的显著上涨。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.